Europe ECG Device Market 2024-2030

    In Stock

    EUROPE ECG DEVICE MARKET

    INTRODUCTION

    An electrocardiogram (ECG) is one of the most basic and quick procedures for evaluating the heart. Electrodes (tiny, plastic patches that adhere to the skin) are inserted at strategic locations on the chest, arms, and legs. Lead cables connect the electrodes to an ECG machine. The heart’s electrical activity is then monitored, analyzed, and printed. No electricity is sent to the body.

     

    Natural electrical impulses regulate contractions of various sections of the heart to keep blood flowing normally. An ECG captures these impulses to reveal how quickly the heart is beating, the rhythm of the heart beats (steady or irregular), and the intensity and timing of the electrical impulses as they travel through the various sections of the heart.

     

    Doctor may order an electrocardiogram (ECG) for a variety of reasons, including: To determine the source of chest pain, to assess heart-related issues such as extreme weariness, shortness of breath, dizziness, or fainting and detecting irregular heartbeats.

     

    To aid in determining the general health of the heart prior to treatments such as surgery; or following therapy for problems such as a heart attack (myocardial infarction, or MI), endocarditis (inflammation or infection of one or more heart valves); or following heart surgery or cardiac catheterization, to examine how a pacemaker implanted works, to assess the efficacy of various cardiac medications and obtaining a baseline trace of the heart’s function during a physical checkup.

     

    The electrical impulses in the heart are recorded by an electrocardiogram. It’s a frequent and painless test for detecting heart issues and monitoring heart health.

     

    An electrocardiogram, commonly known as an ECG or EKG, is frequently performed at a doctor’s office, clinic, or hospital room. ECG devices are commonplace in operating rooms and ambulances. ECG monitoring is available in several personal gadgets, such as smartwatches.

     

    An ECG is a noninvasive, painless method of diagnosing many common cardiac issues. An ECG may be used by a healthcare professional to determine or detect:

     

    Arrhythmias are irregular heartbeats. If blocked or restricted arteries in the heart (coronary artery disease) cause chest discomfort or a heart attack, consult a doctor and whether if have ever suffered a heart attack.

    .

    If the test is normal, the heart should beat at an equal pace of 60 to 100 beats per minute. An ECG can reveal a variety of cardiac disorders, such as a rapid, slow, or irregular heart rhythm, a heart defect, coronary artery disease, heart valve disease, or an enlarged heart.

     

    If symptoms appear and disappear, they may be undetected during a normal ECG recording. A doctor may advise to use remote or continuous ECG monitoring. There are various varieties.

     

    Holter monitoring device. A Holter monitor is a tiny, wearable device that continuously records an ECG for 24 to 48 hours.Event tracking. This portable gadget is comparable to a Holter monitor, except it only records for a few minutes at a time at specific periods.

    It may be worn for a longer period of time than a Holter monitor, often 30 days. When experiencing symptoms, people usually press a button. When an unusual rhythm is recognised, certain devices begin recording automatically.

     

    EUROPE ECG DEVICE MARKET SIZE AND FORECAST

     

    infographic:Europe Ecg Device Market , Europe Ecg Device Market Size, Europe Ecg Device Market Trend, Europe Ecg Device Market ForeCast, Europe Ecg Device Market Risks, Europe Ecg Device Market Report, Europe Ecg Device Market Share

     

     

    The Europe ECG Device Market accounted for $XX Billion in 2023 and is anticipated to reach $XX Billion by 2030, registering a CAGR of XX% from 2024 to 2030.

     

    EUROPE ECG DEVICE MARKET NEW PRODUCT LAUNCH

    Fitbit’s newest smartwatch has received medical device authorization in the United States and Europe, allowing it to fully utilize its ECG software to assist in the identification of cases of the abnormal heart rhythm known as atrial fibrillation.

     

    The Fitbit Sense app, which has received FDA approval and a CE mark, will be available in the United States, some European nations, Hong Kong, and India beginning in October.Fitbit has always prioritized assisting individuals in understanding and managing their heart health, and the new ECG app is geared for customers who wish to examine themselves in the moment and analyze the results later with their doctor.

     

    Fitbit debuted its new Sense smartwatch in late 2016, following a lengthy series of heart-rate trackers. A user can obtain a 30-second, single-lead reading of their heart’s electrical activity by touching their fingers on the stainless steel ring on the face of the watch—a spot-check if they observe any odd cardiac symptoms.

     

    Atrial fibrillation can be difficult to identify early, before the fast, irregular rhythm causes major problems such as stroke, with many patients discovering they have afib only after a stroke has occurred.

     

    Physicians are frequently in the dark about patients’ daily lives in between office visits, and have long believed in the promise of wearable devices to help keep better connected and leverage real-world, individual data to give more informed, personalized treatment.

     

    The Sense wristwatch also includes a thermometer and a sensor that measures changes in the electrical conductivity of the skin, which is commonly used in polygraph lie-detector tests but is now utilized to assist the wearer track and manage their stress levels.

     

    Fitbit started big research earlier this year to investigate the efficacy of its more popular heart rate tracking technology—photoplethysmography, or PPG, which uses light-based sensors to track blood flow through the skin—to identify abnormal cardiac rhythms that might be connected to afib.

     

    EUROPE ECG DEVICE MARKET COMPANY PROFILES

    • Fitbit
    • Nitto Denko
    • Huawei
    • Heartbeam
    • VectraCor

    THIS EUROPE ECG DEVICE MARKET REPORT WILL ANSWER FOLLOWING QUESTIONS

    1. How many  Europe ECG Device Market are manufactured per annum in Europe? Who are the sub-component suppliers in different regions?
    2. Cost breakup of a Europe ECG Device Market  and key vendor selection criteria
    3. Where is the Europe ECG Device Market  manufactured? What is the average margin per unit?
    4. Market share of Europe ECG Device Market manufacturers and their upcoming products
    5. Cost advantage for OEMs who manufacture Europe ECG Device Market in-house
    6. 5 key predictions for next 5 years in Europe ECG Device Market
    7. Average B-2-B  Europe ECG Device Market price in all segments
    8. Latest trends in  Europe ECG Device Market, by every market segment
    9. The market size (both volume and value) of the  Europe ECG Device Market in 2024-2030 and every year in between?
    10. Production breakup of  Europe ECG Device Market, by suppliers and their OEM relationship
    1 Market Segmentation
    2 Scope of the report
    3 Abbreviations
    4 Research Methodology
    5 Executive Summary
    6 Introduction
    7 Insights from Industry stakeholders
    8 Cost breakdown of Product by sub-components and average profit margin
    9 Disruptive innovation in the Industry
    10 Technology trends in the Industry
    11 Consumer trends in the industry
    12 Recent Production Milestones
    13 Component Manufacturing in US, EU and China
    14 COVID-19 impact on overall market
    15 COVID-19 impact on Production of components
    16 COVID-19 impact on Point of sale
    17 Market Segmentation, Dynamics and Forecast by Geography, 2024-2030
    18 Market Segmentation, Dynamics and Forecast by Product Type, 2024-2030
    19 Market Segmentation, Dynamics and Forecast by Application, 2024-2030
    20 Market Segmentation, Dynamics and Forecast by End use, 2024-2030
    21 Product installation rate by OEM, 2023
    22 Incline/Decline in Average B-2-B selling price in past 5 years
    23 Competition from substitute products
    24 Gross margin and average profitability of suppliers
    25 New product development in past 12 months
    26 M&A in past 12 months
    27 Growth strategy of leading players
    28 Market share of vendors, 2023
    29 Company Profiles
    30 Unmet needs and opportunity for new suppliers
    31 Conclusion
    32 Appendix
     
    0
      0
      Your Cart
      Your cart is emptyReturn to Shop